Resultados de la búsqueda 2461-2470 of 15105 for regular exercise

  1. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  2. Epididimitis - Mayo Clinic

    Se puede reimprimir una sola copia de estos materiales para usar en forma personal y no comercial. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy ...

  3. Oncología (médica) - Ensayos clínicos

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  4. Oncología (médica) - Ensayos clínicos

    Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

  5. Oncología (médica) - Ensayos clínicos

    This study does not involve experimental treatment of any ocular tumor, but rather observation of tumor natural history or outcomes following standard of care ...

  6. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, ...

  7. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) ...

  8. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as ...

  9. Oncología (médica) - Ensayos clínicos

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the ...

  10. Oncología (médica) - Ensayos clínicos

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...